Diamond Biofund Inc.

Name

Diamond Biofund Inc.

Legal name

鑽石生技投資股份有限公司

Website

https://diamondbiofund.com

Company type

Public

Founded year

2013

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Headquarters

HQ city

Taipei

HQ country

Taiwan

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations

Revenue model

1. Investment Returns: As a venture capital firm, Diamond Biofund generates returns through capital appreciation and exit events from its portfolio of biotech investments. Revenue is primarily derived from changes in fair value of investments measured under IFRS.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Diamond Biofund Inc. is a venture capital and private equity firm that invests in life sciences, biotechnology, and healthcare companies. The firm manages two core venture capital funds (Diamond Biofund I and Diamond Biofund II) that provide equity capital to innovative biotech companies developing new drugs, high-end medical devices, healthcare services, and agricultural biotechnology. The firm leverages 25+ years of drug development experience to support portfolio companies from laboratory research through commercialization.

Product overview

Diamond Biofund Inc. is a sustainable biotech venture capital firm (永續型生技創投) that operates as a unified investment platform. The company manages two venture capital funds—Diamond Biofund I and Diamond Biofund II—and maintains a portfolio of approximately 11 biotech companies. The firm focuses on identifying and investing in top-tier biotech targets, providing comprehensive professional resources backed by over 25 years of new drug development experience, and working to build flagship biotech companies in partnership with major financial holding companies to achieve maximum investment returns.

Differentiator

Problem solved

Functional benefit

Products and services

• Diamond Biofund I (鑽石一號投資股份有限公司)
• Diamond Biofund II (鑽石高新投資股份有限公司)

Named customers5 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Five partnerships are on record, tiered core and minor.

• Taiwan Stock ExchangecoreStrategic or Co-development PartnerCo-host of the annual Asia Pacific Biotech Investment Forum, bringing together over 500 industry experts.
• Taipei ExchangecoreStrategic or Co-development PartnerCo-host of the annual Asia Pacific Biotech Investment Forum with Taiwan Stock Exchange.
• Taiwan Bio-Development FoundationcoreStrategic or Co-development PartnerFounded by Diamond Biofund to cultivate biomedical talent in Taiwan. Annual contributions of NT$20 million, with NT$100 million initial endowment. Has produced 160 PhD students, 270 master's students, and over 100 postdoctoral researchers.
• Taiwan Venture Capital AssociationminorStrategic or Co-development PartnerDiamond Biofund serves as a director of the Taiwan Venture Capital Association and actively participates in association activities.
• Lovely Taiwan FoundationminorStrategic or Co-development PartnerDiamond Biofund contributes NT$5 million annually to support community, cultural, educational, and arts programs in Nan-Zhou, Pingtung.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Regional players

• Taiwania Capital: Taiwan-based venture capital firm backed by National Development Council with a CVC mandate across technology and biotech. Comparable to Diamond Biofund as a domestic VC competitor focused on Taiwan biotech opportunities.

Direct peers

• RA Capital Management: Healthcare-focused investment firm with a venture and public-equity approach to biotech. Comparable to Diamond Biofund in deploying long-term capital across the biotech development cycle with deep sector expertise.
• Vivo Capital: US-based healthcare/biotech-focused venture capital firm with strong Asia-Pacific exposure. Comparable to Diamond Biofund in its life sciences investment thesis and focus on backing biotech companies through clinical and commercial milestones.
• Atlas Venture: Early-stage biotech venture capital firm that builds companies around academic science. Directly comparable in its model of providing both capital and operational resources to translate research into biotech products.
• OrbiMed Advisors: Leading global healthcare-dedicated investment firm spanning venture, growth, and public equities. Comparable to Diamond Biofund as a specialist biotech investor with multi-stage life sciences mandates and active portfolio support.
• ARCH Venture Partners: Pioneering US biotech VC firm that partners with leading academic institutions to launch and build biotech companies. Directly comparable to Diamond Biofund in leveraging academic talent networks to source and incubate new drug development opportunities.
• 5AM Ventures: US-based early-stage biotech venture capital firm. Comparable in its focused thesis on building biotech companies from academic research, similar to Diamond Biofund's "lab to market" positioning.
• Hotung Investment: Taiwan-listed venture capital firm (TWSE 3105) with a long-running technology/biotech investment focus. Closely comparable to Diamond Biofund as another publicly listed Taiwanese VC with a similar investment mandate and domestic shareholder base.

Broad incumbents

• Burrill & Company: Long-standing life sciences advisory and investment firm. Historically comparable to Diamond Biofund in its dedicated biotech investment and advisory franchise, though broader in scope.
• Temasek Holdings (Life Sciences): Singapore sovereign wealth investor with significant healthcare/biotech allocations across its portfolio. Broader in mandate but a relevant Asia-Pacific investor in life sciences, sharing Diamond Biofund's interest in regional biotech themes.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments10 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Diamond Biofund Inc.